Literature DB >> 2667101

Influenza B in transplant patients.

J Aschan1, O Ringdén, P Ljungman, J Andersson, I Lewensohn-Fuchs, M Forsgren.   

Abstract

Six cases of influenza B occurred in transplanted patients in a period of 3 weeks. Three renal allograft recipients recovered within 5 days without antiviral therapy. Two allogeneic bone marrow recipients were treated with ribavirin inhalations during the leukopenic phase. Treatment was given until influenza B was no longer detected and fever disappeared after 5 and 6 days, respectively. Engraftment was not delayed and no side-effects were noted. One recipient of autologous marrow was treated for 2 days, but ribavirin was discontinued due to pleuritic pain. We conclude that influenza B can be spread by asymptomatic carriers in the nursing staff and in spite of reversed isolation with the use of gown, hand wash and gloves.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2667101     DOI: 10.3109/00365548909035710

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  8 in total

Review 1.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

Review 2.  Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols.

Authors:  Andrea Duchini; John A Goss; Saul Karpen; Paul J Pockros
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 3.  Vaccination against classical influenza in health-care workers: self-protection and patient protection.

Authors:  Sabine Wicker; Holger F Rabenau; Volkhard A J Kempf; Christian Brandt
Journal:  Dtsch Arztebl Int       Date:  2009-09-04       Impact factor: 5.594

4.  Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients.

Authors:  Nathalie Dhédin; Anne Krivine; Nicole Le Corre; Alain Mallet; Bruno Lioure; Jacques-Olivier Bay; Marie-Thérèse Rubio; Philippe Agape; Anne Thiébaut; Jérôme Le Goff; Brigitte Autran; Patricia Ribaud
Journal:  Vaccine       Date:  2013-12-12       Impact factor: 3.641

Review 5.  Respiratory viral infections in immunocompetent and immunocompromised persons.

Authors:  R B Couch; J A Englund; E Whimbey
Journal:  Am J Med       Date:  1997-03-17       Impact factor: 4.965

Review 6.  Community respiratory virus infections in immunocompromised patients with cancer.

Authors:  E Whimbey; J A Englund; R B Couch
Journal:  Am J Med       Date:  1997-03-17       Impact factor: 4.965

7.  Molecular characterization of a nosocomial outbreak of influenza B virus in an acute care hospital setting.

Authors:  M Sansone; Å Wiman; M L Karlberg; M Brytting; L Bohlin; L-M Andersson; J Westin; R Nordén
Journal:  J Hosp Infect       Date:  2018-08-23       Impact factor: 3.926

Review 8.  Infections in neutropenic patients I: aetiology.

Authors:  P Engervall; M Björkholm
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.